Article info
PDFPostScript
Correspondence
Molecular profiling and targeted inhibitor therapy in atypical chronic myeloid leukaemia in blast crisis
- Correspondence to Dr Stephen E Langabeer, Cancer Molecular Diagnostics, Central Pathology Laboratory, St. James’s Hospital, Dublin 8, Ireland; slangabeer{at}stjames.ie
Citation
Molecular profiling and targeted inhibitor therapy in atypical chronic myeloid leukaemia in blast crisis
Publication history
- Received June 13, 2017
- Accepted July 19, 2017
- First published August 3, 2017.
Online issue publication
November 20, 2017
Article Versions
- Previous version (3 August 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.